Loading…

Economic impact of an outbreak of carbapenemase producing-Enterobacteriaceae in a surgical intensive care unit

A 15-month outbreak of carbapenemase-producing Enterobacterales (CPE) occurred in the surgical intensive care unit (SICU) of our institution. We aimed to estimate the financial impact of this outbreak from the perspective of the French public health insurance system. The characteristics of the colon...

Full description

Saved in:
Bibliographic Details
Published in:Anaesthesia critical care & pain medicine 2022-08, Vol.41 (4), p.101093-101093, Article 101093
Main Authors: Atchade, Enora, Goldstein, Valérie, Viane, Sophie, Van Gysel, Damien, Lolom, Isabelle, Lortat-Jacob, Brice, Tran-Dinh, Alexy, Ben Rehouma, Mouna, Lucet, Jean-Christophe, Montravers, Philippe
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A 15-month outbreak of carbapenemase-producing Enterobacterales (CPE) occurred in the surgical intensive care unit (SICU) of our institution. We aimed to estimate the financial impact of this outbreak from the perspective of the French public health insurance system. The characteristics of the colonised/infected CPE patients and outbreak management according to French national guidelines were prospectively collected. Loss of productivity was assessed in terms of the reduction in total number of admissions (TNA) and discharges and in ICU length of stay (LoS). The additional financial burden associated with this outbreak was estimated by the accounting department of the hospital, including the impact of the extended LoS and restricted admissions. Sixteen CPE patients (19 stays) were hospitalised in the SICU (10/2016−01/2018). The median ICU LoS for the CPE cases was 17 [8–36] days versus 6.5 and 6.1 days in 2016 and 2017, respectively, for the whole SICU population. The total number of lost bed days during the outbreak was 452. The TNA dropped dramatically in 2017 (decrease of 20.6%). The estimated costs were 768,386 EUR for bed days lost; 297,176 EUR and 63,675 EUR for the extended LoS for the CPE cases and the patients on contact precautions, respectively; 34,045 EUR for staff reinforcements; 85,764 EUR for bacteriological screening tests; and 42,857 EUR for antimicrobial treatment. The total financial burden of the outbreak was 1,291,903 EUR. Management of a CPE outbreak in the SICU is associated with a huge financial burden for the unit and for the institution.
ISSN:2352-5568
2352-5568
DOI:10.1016/j.accpm.2022.101093